Compares a glucose-monitoring device with blood tests in diabetes
Compares a device that measures glucose without blood samples to blood tests.
Plain-language title generated from the registry record
Registry title: The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
Key facts
- Where
- Springdale, United StatesSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 25 to 65 with type 1 or type 2 diabetes. It compares a glucose device that needs no blood sample with blood tests.
- Age
- 25 to 65 years
- Sex
- Men and women can join.
- Disease stage
- Diagnosed with type 1 or type 2 diabetes.
- Earlier treatment
- No other research study in the last 30 days. No blood transfusion or severe blood loss in the last 14 days.
Main reasons for not taking part
- Taking drugs of abuse (illegal and/or prescription)
- In another research study in the last 30 days
- Blood transfusion or severe blood loss in the last 14 days
- Sickle Cell Anemia
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 65 years old?
Source: NCT05055804, who can take part
Where in United States
- Rouse Family Medical ClinicSpringdale, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- XP Technology, LLC
- Trial code
- NCT05055804
- Record updated
- 16 January 2025
- Original description
This study is an investigational study of the ELG medical device to monitor glucose blood level in diabetes mellitus Type 1 and 2 without blood samples in comparison to blood testing methods."Investigational" means the ELG medical device is subjected by the FDA (Food and Drug Administration) for premarket testing requirements. The purpose of this study is to collect data comparison values between ELG testing device to current blood testing methods.Read full original descriptionShow less
The ELG Analysis of Glucose a Correlational to Blood Glucose Assa
This study is an investigational study of the ELG medical device to monitor glucose blood level in diabetes mellitus Type 1 and 2 without blood samples in comparison to blood testing methods."Investigational" means the ELG medical device is subjected by the FDA (Food and Drug Administration) for premarket testing requirements. The purpose of this study is to collect data comparison values between ELG testing device to current blood testing methods.
Inclusion: Have been diagnosed with type 1 or 2 diabetes; Be 25 - 65 years of age; Male or female; Various ethnicities are desired; Must be available for 2 visits within a 2-4 week period and willing to spend up to 1-2 hours/visit; Must have daytime availability for visits; Able to have 1 venous blood draw \& up to 4 fingersticks for complete blood testing at each visit; Must be willing and able to fast (for at least 6 hours) prior to first visit.
Exclusion: Taking drugs of abuse (illegal and/or prescription); Have been in another research study in the last 30 days; Have had a blood transfusion or severe blood loss in the last 14 days; Have Sickle Cell Anemia.